Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Evaluation of three behavioural economics 'nudges' on grocery and convenience store sales of promoted nutritious foods.

Chapman LE, Sadeghzadeh C, Koutlas M, Zimmer C, De Marco M.

Public Health Nutr. 2019 Dec;22(17):3250-3260. doi: 10.1017/S1368980019001794. Epub 2019 Jul 23.

PMID:
31331404
2.

Pilot Evaluation of Aggregate Plate Waste as a Measure of Students' School Lunch Consumption.

Chapman LE, Richardson S, McLeod L, Rimm E, Cohen J.

J Acad Nutr Diet. 2019 Dec;119(12):2093-2098. doi: 10.1016/j.jand.2019.04.001. Epub 2019 May 29.

PMID:
31153958
3.

Factors Associated with School Lunch Consumption: Reverse Recess and School "Brunch".

Chapman LE, Cohen J, Canterberry M, Carton TW.

J Acad Nutr Diet. 2017 Sep;117(9):1413-1418. doi: 10.1016/j.jand.2017.04.016. Epub 2017 Jun 15.

PMID:
28623163
4.

Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes: A systematic review and meta-analysis.

Chapman LE, Darling AL, Brown JE.

Diabetes Metab. 2016 Nov;42(5):316-327. doi: 10.1016/j.diabet.2016.03.008. Epub 2016 Apr 26. Review.

PMID:
27130885
5.

Classification, location and legitimacy of web-based suppliers of Viagra to the UK.

Gallagher CT, Chapman LE.

Int J Pharm Pract. 2010 Dec;18(6):341-5. doi: 10.1111/j.2042-7174.2010.00061.x. Epub 2010 Sep 28.

PMID:
21054594
6.

Utilization of surgical resources during the USNS COMFORT humanitarian mission to the Americas, June to October 2007.

Hartgerink BJ, Chapman LE, Stevenson J, Donahue TF, Pagliara C.

Mil Med. 2010 Sep;175(9):638-46.

PMID:
20882925
7.

In memoriam: Jonathan S. Allan, DVM (1952-2009).

Chapman LE.

Arch Virol. 2010;155(1):3-5. doi: 10.1007/s00705-009-0566-7. No abstract available.

PMID:
20012659
8.

Xenotransplantation, xenogeneic infections, biotechnology, and public health.

Chapman LE.

Mt Sinai J Med. 2009 Oct;76(5):435-41. doi: 10.1002/msj.20131. Review.

9.

Influenza vaccination coverage among adult solid organ transplant recipients at three health maintenance organizations, 1995-2005.

Harris K, Baggs J, Davis RL, Black S, Jackson LA, Mullooly JP, Chapman LE.

Vaccine. 2009 Apr 14;27(17):2335-41. doi: 10.1016/j.vaccine.2009.02.026. Epub 2009 Feb 20.

PMID:
19428848
10.

How medicine advances.

Chapman LE.

Clin Infect Dis. 2009 Feb 15;48(4):407-9. doi: 10.1086/596310. No abstract available.

PMID:
19143529
11.

Postexposure interventions to prevent infection with HBV, HCV, or HIV, and tetanus in people wounded during bombings and other mass casualty events--United States, 2008: recommendations of the Centers for Disease Control and Prevention and Disaster Medicine and Public Health Preparedness.

Chapman LE, Sullivent EE, Grohskopf LA, Beltrami EM, Perz JF, Kretsinger K, Panlilio AL, Thompson ND, Ehrenberg RL, Gensheimer KF, Duchin JS, Kilmarx PH, Hunt RC.

Disaster Med Public Health Prep. 2008 Oct;2(3):150-65. doi: 10.1097/DMP.0b013e318187ac66.

PMID:
18677271
12.

Recommendations for postexposure interventions to prevent infection with hepatitis B virus, hepatitis C virus, or human immunodeficiency virus, and tetanus in persons wounded during bombings and other mass-casualty events--United States, 2008: recommendations of the Centers for Disease Control and Prevention (CDC).

Chapman LE, Sullivent EE, Grohskopf LA, Beltrami EM, Perz JF, Kretsinger K, Panlilio AL, Thompson ND, Ehrenberg RL, Gensheimer KF, Duchin JS, Kilmarx PH, Hunt RC; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2008 Aug 1;57(RR-6):1-21; quiz CE1-4.

13.

A process for sentinel case review to assess causal relationships between smallpox vaccination and adverse outcomes, 2003-2004.

Chapman LE, Iskander JK, Chen RT, Neff J, Birkhead GS, Poland G, Gray GC, Siegel J, Sepkowitz K, Robertson RM, Yancy C, Guerra FA, Gardner P, Modlin JF, Maurer T, Berger T, Flanders WD, Shope R.

Clin Infect Dis. 2008 Mar 15;46 Suppl 3:S271-93. doi: 10.1086/524750.

PMID:
18284368
14.

Myocarditis, pericarditis, and dilated cardiomyopathy after smallpox vaccination among civilians in the United States, January-October 2003.

Morgan J, Roper MH, Sperling L, Schieber RA, Heffelfinger JD, Casey CG, Miller JW, Santibanez S, Herwaldt B, Hightower P, Moro PL, Hibbs BF, Levine NH, Chapman LE, Iskander J, Lane JM, Wharton M, Mootrey GT, Swerdlow DL.

Clin Infect Dis. 2008 Mar 15;46 Suppl 3:S242-50. doi: 10.1086/524747.

PMID:
18284365
15.

Introduction: vaccination against smallpox in the posteradication era.

Chapman LE, Mootrey GT, Neff LJ.

Clin Infect Dis. 2008 Mar 15;46 Suppl 3:S153-6. doi: 10.1086/524379.

PMID:
18284354
16.

Clinical and virological characterization of persistent human infection with simian foamy viruses.

Boneva RS, Switzer WM, Spira TJ, Bhullar VB, Shanmugam V, Cong ME, Lam L, Heneine W, Folks TM, Chapman LE.

AIDS Res Hum Retroviruses. 2007 Nov;23(11):1330-7. doi: 10.1089/aid.2007.0104.

PMID:
18184074
17.

Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions.

Casey C, Vellozzi C, Mootrey GT, Chapman LE, McCauley M, Roper MH, Damon I, Swerdlow DL; Vaccinia Case Definition Development Working Group; Advisory Committee on Immunization Practices-Armed Forces Epidemiological Board Smallpox Vaccine Safety Working Group.

MMWR Recomm Rep. 2006 Feb 3;55(RR-1):1-16.

18.

Neurologic adverse events associated with smallpox vaccination in the United States, 2002-2004.

Sejvar JJ, Labutta RJ, Chapman LE, Grabenstein JD, Iskander J, Lane JM.

JAMA. 2005 Dec 7;294(21):2744-50. Erratum in: JAMA. 2005 Dec 28;294(24):3092. JAMA. 2007 Oct 24;298(16):1864.

PMID:
16333010
19.

Adverse events associated with smallpox vaccination in the United States, January-October 2003.

Casey CG, Iskander JK, Roper MH, Mast EE, Wen XJ, Török TJ, Chapman LE, Swerdlow DL, Morgan J, Heffelfinger JD, Vitek C, Reef SE, Hasbrouck LM, Damon I, Neff L, Vellozzi C, McCauley M, Strikas RA, Mootrey G.

JAMA. 2005 Dec 7;294(21):2734-43.

PMID:
16333009
20.

Mucosal and systemic antibody responses in humans infected with simian foamy virus.

Cummins JE Jr, Boneva RS, Switzer WM, Christensen LL, Sandstrom P, Heneine W, Chapman LE, Dezzutti CS.

J Virol. 2005 Oct;79(20):13186-9.

21.

Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates.

Switzer WM, Bhullar V, Shanmugam V, Cong ME, Parekh B, Lerche NW, Yee JL, Ely JJ, Boneva R, Chapman LE, Folks TM, Heneine W.

J Virol. 2004 Mar;78(6):2780-9.

22.

Xenotransplantation: public health risks--patient vs. society in an emerging field.

Chapman LE.

Curr Top Microbiol Immunol. 2003;278:23-45. Review.

PMID:
12934940
23.

Implications of the advent of homozygous alpha l, 3-galactosyltransferase gene-deficient pigs on transmission of infectious agents.

Chapman LE, Wilson CA.

Xenotransplantation. 2003 Jul;10(4):287-8. Review. No abstract available.

PMID:
12795676
24.

Recommendations for prevention of and therapy for exposure to B virus (cercopithecine herpesvirus 1).

Cohen JI, Davenport DS, Stewart JA, Deitchman S, Hilliard JK, Chapman LE; B Virus Working Group.

Clin Infect Dis. 2002 Nov 15;35(10):1191-203. Epub 2002 Oct 17.

PMID:
12410479
25.

Simian foamy virus infection in a blood donor.

Boneva RS, Grindon AJ, Orton SL, Switzer WM, Shanmugam V, Hussain AI, Bhullar VB, Chamberland ME, Heneine W, Folks TM, Chapman LE.

Transfusion. 2002 Jul;42(7):886-91.

PMID:
12375661
26.

Discriminators between hantavirus-infected and -uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndrome.

Chapman LE, Ellis BA, Koster FT, Sotir M, Ksiazek TG, Mertz GJ, Rollin PE, Baum KF, Pavia AT, Christenson JC, Rubin PJ, Jolson HM, Behrman RE, Khan AS, Bell LJ, Simpson GL, Hawk J, Holman RC, Peters CJ; Ribavirin Study Group.

Clin Infect Dis. 2002 Feb 1;34(3):293-304. Epub 2001 Dec 13.

PMID:
11774075
27.

Genetic characterization of wild-type genotype VII hepatitis A virus.

Ching KZ, Nakano T, Chapman LE, Demby A, Robertson BH.

J Gen Virol. 2002 Jan;83(Pt 1):53-60.

PMID:
11752700
28.

Lack of cross-species transmission of porcine endogenous retrovirus infection to nonhuman primate recipients of porcine cells, tissues, or organs.

Switzer WM, Michler RE, Shanmugam V, Matthews A, Hussain AI, Wright A, Sandstrom P, Chapman LE, Weber C, Safley S, Denny RR, Navarro A, Evans V, Norin AJ, Kwiatkowski P, Heneine W.

Transplantation. 2001 Apr 15;71(7):959-65.

PMID:
11349732
29.

Clinical xenotransplantation.

Chapman LE, Bloom ET.

JAMA. 2001 May 9;285(18):2304-6. No abstract available.

PMID:
11343460
30.

Evidence of infection with simian type D retrovirus in persons occupationally exposed to nonhuman primates.

Lerche NW, Switzer WM, Yee JL, Shanmugam V, Rosenthal AN, Chapman LE, Folks TM, Heneine W.

J Virol. 2001 Feb;75(4):1783-9.

31.

Infectious disease issues in xenotransplantation.

Boneva RS, Folks TM, Chapman LE.

Clin Microbiol Rev. 2001 Jan;14(1):1-14. Review.

32.

Effect of clinical events on plasma HIV-1 RNA levels in persons with CD4+ T-lymphocyte counts of more than 500 x 10(6) cells/l.

Chapman LE, Green TA, Ahmed F, Parekh BS, Rimland D, Kaplan JE, Thompson MA, Folks TM.

AIDS. 2000 Jun 16;14(9):1135-46.

PMID:
10894277
33.

Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Ribavirin Study Group.

Chapman LE, Mertz GJ, Peters CJ, Jolson HM, Khan AS, Ksiazek TG, Koster FT, Baum KF, Rollin PE, Pavia AT, Holman RC, Christenson JC, Rubin PJ, Behrman RE, Bell LJ, Simpson GL, Sadek RF.

Antivir Ther. 1999;4(4):211-9.

PMID:
10723500
34.

Survey of veterinary conference attendees for evidence of zoonotic infection by feline retroviruses.

Butera ST, Brown J, Callahan ME, Owen SM, Matthews AL, Weigner DD, Chapman LE, Sandstrom PA.

J Am Vet Med Assoc. 2000 Nov 15;217(10):1475-9.

PMID:
11128537
35.

Xenogeneic infections and public health.

Chapman LE.

Clin Exp Pharmacol Physiol. 1999 Dec;26(12):1005-8. Review.

PMID:
10626071
36.

Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group.

Paradis K, Langford G, Long Z, Heneine W, Sandstrom P, Switzer WM, Chapman LE, Lockey C, Onions D, Otto E.

Science. 1999 Aug 20;285(5431):1236-41.

37.

Xenotransplantation: the potential and the challenges.

Bloom ET, Moulton AD, McCoy J, Chapman LE, Patterson AP.

Crit Care Nurse. 1999 Apr;19(2):76-83. Review.

PMID:
10401305
38.

Xenotransplantation: the potential for xenogeneic infections.

Chapman LE, Heneine W, Switzer W, Sandstrom P, Folks TM.

Transplant Proc. 1999 Feb-Mar;31(1-2):909-10. No abstract available.

PMID:
10083399
39.

Xenotransplantation and the risk of retroviral zoonosis.

Brown J, Matthews AL, Sandstrom PA, Chapman LE.

Trends Microbiol. 1998 Oct;6(10):411-5.

PMID:
9807786
40.

No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts.

Heneine W, Tibell A, Switzer WM, Sandstrom P, Rosales GV, Mathews A, Korsgren O, Chapman LE, Folks TM, Groth CG.

Lancet. 1998 Aug 29;352(9129):695-9. Erratum in: Lancet 1998 Oct 31;352(9138):1478.

PMID:
9728986
41.

Xenotransplantation: Is the future upon us?

Pearson ML, Jarvis WR, Folks TM, Chapman LE.

Infect Control Hosp Epidemiol. 1998 May;19(5):305-7. No abstract available.

PMID:
9613689
42.

Identification of a human population infected with simian foamy viruses.

Heneine W, Switzer WM, Sandstrom P, Brown J, Vedapuri S, Schable CA, Khan AS, Lerche NW, Schweizer M, Neumann-Haefelin D, Chapman LE, Folks TM.

Nat Med. 1998 Apr;4(4):403-7.

PMID:
9546784
43.

Hantavirus pulmonary syndrome: the first 100 US cases.

Khan AS, Khabbaz RF, Armstrong LR, Holman RC, Bauer SP, Graber J, Strine T, Miller G, Reef S, Tappero J, Rollin PE, Nichol ST, Zaki SR, Bryan RT, Chapman LE, Peters CJ, Ksiazek TG.

J Infect Dis. 1996 Jun;173(6):1297-303.

PMID:
8648200
44.

Xenotransplantation and xenogeneic infections.

Chapman LE, Folks TM, Salomon DR, Patterson AP, Eggerman TE, Noguchi PD.

N Engl J Med. 1995 Nov 30;333(22):1498-501. No abstract available.

PMID:
7477153
45.

Guidelines on the risk for transmission of infectious agents during xenotransplants.

Chapman LE.

Emerg Infect Dis. 1995 Oct-Dec;1(4):156. No abstract available.

46.

Guidelines for the prevention and treatment of B-virus infections in exposed persons. The B virus Working Group.

Holmes GP, Chapman LE, Stewart JA, Straus SE, Hilliard JK, Davenport DS.

Clin Infect Dis. 1995 Feb;20(2):421-39.

PMID:
7742451
47.

Etiology and epidemiology of the Four Corners hantavirus outbreak.

Chapman LE, Khabbaz RF.

Infect Agents Dis. 1994 Oct;3(5):234-44. Review.

PMID:
7866656
48.

Rift Valley fever in rural northern Senegal: human risk factors and potential vectors.

Wilson ML, Chapman LE, Hall DB, Dykstra EA, Ba K, Zeller HG, Traore-Lamizana M, Hervy JP, Linthicum KJ, Peters CJ.

Am J Trop Med Hyg. 1994 Jun;50(6):663-75.

PMID:
7912905
49.

Norwalk virus-associated gastroenteritis traced to ice consumption aboard a cruise ship in Hawaii: comparison and application of molecular method-based assays.

Khan AS, Moe CL, Glass RI, Monroe SS, Estes MK, Chapman LE, Jiang X, Humphrey C, Pon E, Iskander JK, et al.

J Clin Microbiol. 1994 Feb;32(2):318-22.

50.

Lack of evidence for infection with known human and animal retroviruses in patients with chronic fatigue syndrome.

Heneine W, Woods TC, Sinha SD, Khan AS, Chapman LE, Schonberger LB, Folks TM.

Clin Infect Dis. 1994 Jan;18 Suppl 1:S121-5.

PMID:
8148438

Supplemental Content

Loading ...
Support Center